Reacción #306455

ord-1bc5bcad1cbc46d9ac5442b603b9d09e

Ecuación de reacción

COc1cnc2ccc(Cc3nnc4ccc(I)nn34)cc2c1
6-((6-iodo-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)-3-methoxyquinoline
Cc1cc(Br)sn1
5-bromo-3-methylisothiazole
C[CH](C)[Mg][Cl]
isopropylmagnesium chloride
CC1(C)c2cccc(P(c3ccccc3)c3ccccc3)c2Oc2c(P(c3ccccc3)c3ccccc3)cccc21
4,5-bis(diphenylphosphino)-9,9-dimethyl-9H-xanthene
COc1cnc2ccc(Cc3nnc4ccc(-c5cc(C)ns5)nn34)cc2c1
3-methoxy-6-((6-(3-methylisothiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)quinoline
Rendimiento 1.6%

Disolventes

Condiciones de reacción

Temperatura
0°CELSIUS
Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Temperaturato warm to rt
  2. 2
    workup.STIRRINGThe mixture was stirred at rt 10 minutes
  3. 3
    workup.STIRRINGthe slurry stirred 10 minutes
  4. 4
    OtroThe flask was fitted with a reflux condenser
  5. 5
    Temperaturaheated with a 90° C. oil bath for 24 h
  6. 6
    workup.ADDITIONadded to the reaction mixture
  7. 7
    Temperaturathe mixture heated at 90° C. for 1 h
  8. 8
    Temperaturato cool to rt
  9. 9
    Lavadoeluted with 200 mL THF
  10. 10
    ConcentraciónThe eluents were concentrated in vacuo
  11. 11
    workup.STIRRINGthe mixture stirred at room temperature for 24 h
  12. 12
    Otrothe solid collected
  13. 13
    LavadoThe solid was washed with EtOH (discarded)
  14. 14
    ConcentraciónThe ammoniacal eluents were concentrated
  15. 15
    Otrothe residue purified by HPLC

Procedimiento

A flask charged with 5-bromo-3-methylisothiazole (0.049 g, 0.28 mmol) and 0.3 mL dry THF was cooled to 0° C., and isopropylmagnesium chloride (0.30 ml, 0.30 mmol) added dropwise over 5 minutes and the mixture stirred an additional 5 minutes before allowing to warm to rt. The mixture was stirred at rt 10 minutes and the mixture cannulated to a solution of zinc(II) chloride (0.30 ml, 0.30 mmol) [1M] and the slurry stirred 10 minutes. The zincate was treated with 6-((6-iodo-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)-3-methoxyquinoline (0.0890 g, 0.21 mmol), 1 mL dry THF, and a preformed solution of 4,5-bis(diphenylphosphino)-9,9-dimethyl-9H-xanthene (0.012 g, 0.021 mmol) and Pd(OAc)2 (0.0024 g, 0.011 mmol) dissolved in 1 mL dry THF. The flask was fitted with a reflux condenser and heated with a 90° C. oil bath for 24 h. The zincate portion of this procedure was repeated, added to the reaction mixture, and the mixture heated at 90° C. for 1 h. The mixture was allowed to cool to rt and loaded onto 10 g of SiO2 wet-packed with THF, and eluted with 200 mL THF. The eluents were concentrated in vacuo, and taken up in 5 mL EtOH. To the solution was added Si-sulfonic acid (1.5 g, 1.1 mmol) and the mixture stirred at room temperature for 24 h, and the solid collected. The solid was washed with EtOH (discarded), and then 2M NH3 in EtOH (5×5 mL). The ammoniacal eluents were concentrated and the residue purified by HPLC to afford 3-methoxy-6-((6-(3-methylisothiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)quinoline (0.0013 g, 1.6% yield).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US08198448B2uspto-grants-2012_06